Publication Date: 2024-03-26
Practice Area: Antitrust | Business Torts
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Barrington D. Parker
Attorneys: For plaintiff: For Plaintiff-Appellant: Joshua Halpern, Elizabeth S. Weiswasser, Eric S. Hochstadt, & Anish R. Desai, on the brief, Adam Banks, Weil, Gotshal & Manges LLP, New York, NY & Washington, D.C.
for defendant: For Defendants-Appellees Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corp.: Ian Simmons, Lisa Pensabene, Stephen J. McIntyre, & Melissa C. Cassel, on the brief, William Jay, O'Melveny & Myers LLP, Washington, D.C., New York, NY, Los Angeles, CA & San Francisco, CA.
Benjamin T. Horton & Julianne M. Hartzell, on the brief, Marshall Gerstein & Borun LLP, Chicago, IL, for Defendant-Appellee Vetter Pharma International GmbH.
Anisha S. Dasgupta & Joel Marcus, on the brief, Matthew M. Hoffman, Federal Trade Commission, Washington, D.C., and Jonathan S. Kanter, Daniel E. Haar, Nickolai G. Levin, & Andrew N. DeLaney, on the brief, United States Department of Justice, Antitrust Division, Washington, D.C., Amici Curiae in Support of Neither Party.
Case Number: 22-0427-cv
Anti-VEGF Medications in Vials, Pre-Filled Syringes Compete in Different Product Markets
1 minute read
